Fig. 3
The follow-up of the lung function test for CAJDM-ILD. (A: Lung function test at admission, VCMAX, FVC, FEV1 and FEV1/VCmax were 0.79 L, 0.73 L, 0.61 L and 0.78, respectively, accounting for 32.2, 30.6, 30.7 and 91.9% of the predicted value; B: Lung function after one-month treatment, VCMAX, FVC, FEV1 and FEV1/VCmax were 1.39 L, 1.39 L, 1.29 L and 0.93, respectively, accounting for 54.6, 56.0, 62.0 and 109.4% of the predicted value; C: Lung function after one-year treatment, VCMAX, FVC, FEV1 and FEV1/VCmax were 2.11 L, 2.11 L, 1.86 L and 0.88, respectively, accounting for 78.0, 79.7, 84.0 and 104.1% of the predicted value; D: Lung function after 2.5-year treatment, VCMAX, FVC, FEV1 and FEV1/VCmax were 2.74 L, 2.74 L, 2.44 L and 0.89, respectively, accounting for 79.2, 79.8, 85.4 and 105.8% of the predicted value; E: Dynamic changes of VCMAX, FVC, FEV1, FEV1/VCMAX in two and a half years)